Literature DB >> 31453592

How membrane lipids influence plasma delivery of reactive oxygen species into cells and subsequent DNA damage: an experimental and computational study.

Jonas Van der Paal1, Sung-Ha Hong2, Maksudbek Yusupov1, Nishtha Gaur3, Jun-Seok Oh4, Robert D Short5, Endre J Szili3, Annemie Bogaerts1.   

Abstract

The mechanisms of plasma in medicine are broadly attributed to plasma-derived reactive oxygen and nitrogen species (RONS). In order to exert any intracellular effects, these plasma-derived RONS must first traverse a major barrier in the cell membrane. The cell membrane lipid composition, and thereby the magnitude of this barrier, is highly variable between cells depending on type and state (e.g. it is widely accepted that healthy and cancerous cells have different membrane lipid compositions). In this study, we investigate how plasma-derived RONS interactions with lipid membrane components can potentially be exploited in the future for treatment of diseases. We couple phospholipid vesicle experiments, used as simple cell models, with molecular dynamics (MD) simulations of the lipid membrane to provide new insights into how the interplay between phospholipids and cholesterol may influence the response of healthy and diseased cell membranes to plasma-derived RONS. We focus on the (i) lipid tail saturation degree, (ii) lipid head group type, and (iii) membrane cholesterol fraction. Using encapsulated molecular probes, we study the influence of the above membrane components on the ingress of RONS into the vesicles, and subsequent DNA damage. Our results indicate that all of the above membrane components can enhance or suppress RONS uptake, depending on their relative concentration within the membrane. Further, we show that higher RONS uptake into the vesicles does not always correlate with increased DNA damage, which is attributed to ROS reactivity and lifetime. The MD simulations indicate the multifactorial chemical and physical processes at play, including (i) lipid oxidation, (ii) lipid packing, and (iii) lipid rafts formation. The methods and findings presented here provide a platform of knowledge that could be leveraged in the development of therapies relying on the action of plasma, in which the cell membrane and oxidative stress response in cells is targeted.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31453592     DOI: 10.1039/c9cp03520f

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  5 in total

1.  Insight into the Impact of Oxidative Stress on the Barrier Properties of Lipid Bilayer Models.

Authors:  Zahra Nasri; Mohsen Ahmadi; Johanna Striesow; Mehdi Ravandeh; Thomas von Woedtke; Kristian Wende
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

Review 2.  Cancer treatment with gas plasma and with gas plasma-activated liquid: positives, potentials and problems of clinical translation.

Authors:  Juliette C Harley; Natalka Suchowerska; David R McKenzie
Journal:  Biophys Rev       Date:  2020-08-05

Review 3.  Safety and Toxicity Issues of Therapeutically Used Nanoparticles from the Oral Route.

Authors:  Farzaneh Lotfipour; Shahriar Shahi; Afsaneh Farjami; Sara Salatin; Mohammad Mahmoudian; Solmaz Maleki Dizaj
Journal:  Biomed Res Int       Date:  2021-10-28       Impact factor: 3.411

4.  Toxicity and virucidal activity of a neon-driven micro plasma jet on eukaryotic cells and a coronavirus.

Authors:  Daniel M Mrochen; Lea Miebach; Henry Skowski; Robert Bansemer; Chiara A Drechsler; Ulfilas Hofmanna; Manuel Hein; Uwe Mamat; Torsten Gerling; Ulrich Schaible; Thomas von Woedtke; Sander Bekeschus
Journal:  Free Radic Biol Med       Date:  2022-08-28       Impact factor: 8.101

5.  Rapid Lipid Modification of Endothelial Cell Membranes in Cardiac Ischemia/Reperfusion Injury: a Novel Therapeutic Strategy to Reduce Infarct Size.

Authors:  Claudio Maldonado; Mai-Dung Nguyen; Phillip Bauer; Shunichi Nakamura; Syed J Khundmiri; Gustavo Perez-Abadia; Heather L Stowers; Wen-Jian Wu; Xian-Liang Tang
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-20       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.